Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 261,152 | 391,803 | 684,717 | 382,869 | 419,311 |
| Marketable Securities | 256,006 | 161,614 | 0 | 3,205 | 18,085 |
| Receivables | 29,765 | 27,730 | 28,800 | 23,894 | 19,544 |
| Inventories | 65,816 | 61,964 | 58,202 | 51,512 | 47,991 |
| TOTAL | $640,011 | $675,648 | $801,970 | $488,864 | $524,859 |
| Non-Current Assets | |||||
| PPE Net | 32,425 | 33,598 | 34,918 | 35,415 | 36,775 |
| Investments And Advances | 146,863 | 108,667 | 50,057 | 30,692 | 0 |
| Other Non-Current Assets | 51,143 | 51,630 | 52,263 | 52,707 | 53,338 |
| TOTAL | $230,431 | $193,895 | $137,238 | $118,814 | $90,113 |
| Total Assets | $870,442 | $869,543 | $939,208 | $607,678 | $614,972 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,260 | 5,422 | 15,097 | 8,642 | 9,198 |
| Accrued Expenses | 78,453 | 66,153 | 67,009 | 59,962 | 58,234 |
| Other current liabilities | 6,379 | 7,730 | 5,892 | N/A | N/A |
| TOTAL | $93,092 | $79,305 | $87,998 | $74,058 | $72,675 |
| Non-Current Liabilities | |||||
| Long Term Debt | 247,130 | 246,738 | 246,352 | 149,508 | 149,268 |
| Other Non-Current Liabilities | 411,860 | 409,498 | 408,448 | 75,812 | 77,263 |
| TOTAL | $658,990 | $656,236 | $654,800 | $225,320 | $226,531 |
| Total Liabilities | $752,082 | $735,541 | $742,798 | $299,378 | $299,206 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,464 | 65,098 | 64,821 | 64,445 | 62,412 |
| Common Shares | 67 | 65 | 65 | 64 | 62 |
| Retained earnings | -1,453,453 | -1,370,983 | -1,289,560 | -1,201,979 | -1,130,991 |
| Other shareholders' equity | -3,973 | -1,962 | 100 | 221 | 302 |
| TOTAL | $118,360 | $134,002 | $196,410 | $308,300 | $315,766 |
| Total Liabilities And Equity | $870,442 | $869,543 | $939,208 | $607,678 | $614,972 |